| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/29/2009 | US7595064 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals |
| 09/29/2009 | US7595051 Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies |
| 09/29/2009 | US7595048 Method for treatment of cancer by inhibiting the immunosuppressive signal induced by PD-1 |
| 09/29/2009 | US7595044 Artery-and vein-specific proteins and uses therefor |
| 09/29/2009 | US7595042 Treating cancer in humans; obtain human, administer antitumor agent, evaluate tumor response to antitumor agents |
| 09/29/2009 | CA2469350C 3-{4-methyl-3[methyl-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile mono citrate salt |
| 09/29/2009 | CA2457944C Polycyclic guanine phosphodiesterase v inhibitors |
| 09/29/2009 | CA2403232C 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds |
| 09/29/2009 | CA2391085C Bis-basic compounds as tryptase inhibitors, processes for preparing them and their use as phamaceutical compositions |
| 09/29/2009 | CA2390295C A method for chemoprevention of prostate cancer |
| 09/29/2009 | CA2348391C Chromenone and chromanone derivatives as integrin inhibitors |
| 09/29/2009 | CA2293433C Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives as farnesyl protein transferase inhibitors |
| 09/29/2009 | CA2217178C Vaccines containing a saponin and a sterol |
| 09/29/2009 | CA2176796C Substituted benzyloxycarbonylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 09/28/2009 | CA2627903A1 Amphoteric microgels for the delivery of compounds to cells |
| 09/24/2009 | WO2009117706A2 Methods of treatment using anti-mif antibodies |
| 09/24/2009 | WO2009117367A1 Method for treating cancers having high glucose requirements employing an sglt2 inhibitor and compositions thereof |
| 09/24/2009 | WO2009117157A1 Aurora kinase modulators and method of use |
| 09/24/2009 | WO2009117116A2 Heat shock protein gp96 vaccination and methods of using same |
| 09/24/2009 | WO2009117097A1 Novel tyrosine kinase inhibitors |
| 09/24/2009 | WO2009117080A1 Quinazoline derivatives as raf kinase modulators and methods of use thereof |
| 09/24/2009 | WO2009116764A2 Cell migration, cell infiltration, or neovascularization inhibitor through degradation of function of ptk7 protein |
| 09/24/2009 | WO2009116670A1 Anti-human dlk-1 antibody having anti-tumor activity in vivo |
| 09/24/2009 | WO2009116556A1 Pharmaceutical composition for injection |
| 09/24/2009 | WO2009116529A1 Polypeptide and pharmaceutical composition containing the polypeptide |
| 09/24/2009 | WO2009116509A1 Polymer conjugate of physiologically active substance |
| 09/24/2009 | WO2009115776A1 Cyclopenta[g]quinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia |
| 09/24/2009 | WO2009115651A2 N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof |
| 09/24/2009 | WO2009115562A2 Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts |
| 09/24/2009 | WO2009115465A1 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
| 09/24/2009 | WO2009115321A1 Midazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators |
| 09/24/2009 | WO2009115213A1 (pyrazolyl carbonyl)imidazolidinone derivatives for the treatment of retroviral diseases |
| 09/24/2009 | WO2009115023A1 A anthocyanins phospholipid complex and the preparative method thereof |
| 09/24/2009 | WO2009114994A1 The use of the pyridazinone derivatives for the manufacture of medicament for anti-tumour |
| 09/24/2009 | WO2009114993A1 Pyridazinones, the preparation and the use thereof |
| 09/24/2009 | WO2009114943A1 Peptide composition for cancer treatment by inhibiting trpv6 calcium channel activity |
| 09/24/2009 | WO2009114942A1 Thymidylate kinase fusions and uses thereof |
| 09/24/2009 | WO2009097233A9 Imidazopyrazines as protein kinase inhibitors |
| 09/24/2009 | WO2009095261A3 Vaccine compositions |
| 09/24/2009 | WO2009089186A3 Peptide-conjugated oligonucleotide therapeutic and method of making and using same |
| 09/24/2009 | WO2009087212A3 Pyridine derivatives |
| 09/24/2009 | WO2009080705A3 Bis-thiazole derivatives, process for their preparation and their use as medicaments |
| 09/24/2009 | WO2009076454A3 Compounds that modulate intracellular calcium |
| 09/24/2009 | WO2009067397A3 Treatment for solid tumors |
| 09/24/2009 | WO2009064486A3 Inhibitors of pim protein kinases, compositions, and methods for treating cancer |
| 09/24/2009 | WO2009061807A3 Activin receptor-like kinase-i antagonist compositions and methods of use |
| 09/24/2009 | WO2009058690A3 Nell-1 compositions |
| 09/24/2009 | WO2009057139A3 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents |
| 09/24/2009 | WO2009047291A3 Use of quaternary pyridinium salts for inhibiting cancer metastases |
| 09/24/2009 | WO2009044273A3 Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response |
| 09/24/2009 | WO2009040068A3 Use of a peptide as a therapeutic agent |
| 09/24/2009 | WO2009040067A3 Use of a peptide as a therapeutic agent |
| 09/24/2009 | WO2009040049A3 Use of acetyl- (ala10, 11)-rantes (1-14) and/or calcitonin as anti-angiogenic agents |
| 09/24/2009 | WO2009033681A3 Cyclo-argd as a therapeutic agent |
| 09/24/2009 | WO2009033680A3 Galanin-like peptide alone or in combination with cyclo-argd as a therapeutic agent |
| 09/24/2009 | WO2009032668A3 2 -biphenylamino-4 -aminopyrimidine derivatives as kinase inhibitors |
| 09/24/2009 | WO2008144423A3 Compositions comprising a gpr109 ligand for treating disorders of the digestive tract and/or cancer |
| 09/24/2009 | WO2008121029A3 Use of 9-oxoacridine-10-acetic acid and/or salts and/or its esters thereof for the treatment and prophylaxis of malignant tumors of female reproductive system |
| 09/24/2009 | WO2008113469A8 Substituted imidazopyrimidines and triazolopyrimidines |
| 09/24/2009 | WO2008065636A3 Treatment of disease by modulating cf5 protein |
| 09/24/2009 | WO2008030119A9 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 09/24/2009 | US20090239955 Novel obovatol derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition for the prevention and treatment of cancer containing the same as an active ingredient |
| 09/24/2009 | US20090239946 Pharmaceutical compositions of HDAC inhibitors and chelatable metal compounds, and metal-HDAC inhibitors chelate complexes |
| 09/24/2009 | US20090239939 Combinations for introducing nucleic acids into cells |
| 09/24/2009 | US20090239937 Apoptosis-Inducing Genes for Treating Cancer |
| 09/24/2009 | US20090239924 1h-furo[3,2-c]pyrazole compounds useful as kinase inhibitors |
| 09/24/2009 | US20090239922 Kinesin inhibitors as cancer therapeutics |
| 09/24/2009 | US20090239921 Methods for treating neoplasms with derivatives of 4,5,6,7-tetrabromobenzimidazole |
| 09/24/2009 | US20090239917 Heterocyclic Cycloalkyl Compounds, a Process for their Preparation and Pharmaceutical Compositions Containing Them |
| 09/24/2009 | US20090239893 Synthesis of gimatecan by reacting an acetal of 7-formyl-camptothecin with O-t-butylhydroxylamine hydrochloride in a polar protic or aprotic organic solvent |
| 09/24/2009 | US20090239889 Spiro[2-cyclohexene-1,3'-[3H]indole]-2',4(1'H)-diones and 4-hydroxyspiro[2-cyclohexene-1,3'-[3H]indol]-2'(1'H)-ones; act as antagonists of mdm2 interactions; useful as potent and selective anticancer agents |
| 09/24/2009 | US20090239885 Inhibitors of nucleoside phoshorylases and nucleosidases |
| 09/24/2009 | US20090239882 Thiazolopyramidine Compounds for the Modulation of Chemokine Receptor Activity |
| 09/24/2009 | US20090239879 N-oxides of n-phenyl-2-pyrimidine-amine derivatives |
| 09/24/2009 | US20090239878 Combinations of (a) an atp-competitive inhibitor of c-abl kinase activity with (b) two or more other antineoplastic agents |
| 09/24/2009 | US20090239872 Treatment of mesothelioma |
| 09/24/2009 | US20090239871 antitumor; breast cancer; 8,9-Dimethoxy-2,3-methylenedioxy-5-[2-(N,N-dimethylamino)ethyl]-5H-dibenzo[c,h]1,6-naphthyridin-6-one |
| 09/24/2009 | US20090239861 Quinazoline derivatives as anticancer agents |
| 09/24/2009 | US20090239860 Novel benzofuran derivative, medicinal composition containing the same, and uses of these |
| 09/24/2009 | US20090239859 Protein kinase modulators |
| 09/24/2009 | US20090239850 Kinase protein binding inhibitors |
| 09/24/2009 | US20090239849 Aryl-Fused Spirocyclic Compounds |
| 09/24/2009 | US20090239839 Receptor antagonist |
| 09/24/2009 | US20090239838 Pyrrolotriazine kinase inhibitors |
| 09/24/2009 | US20090239829 Thioaryl substituted inhibitors of zinc proteases and their use |
| 09/24/2009 | US20090239828 Adhesive preparation |
| 09/24/2009 | US20090239826 Compositions and methods for the regulation of homocysteine levels within the body |
| 09/24/2009 | US20090239820 Compounds and methods for treatment of solid tumors |
| 09/24/2009 | US20090239818 Effective treatment of ovarian cancer using triciribine and related compounds |
| 09/24/2009 | US20090239813 Analogs of Alpha Galactosyceramide and Uses thereof |
| 09/24/2009 | US20090239806 Glypican-3 (gpc3)-derived tumor rejection antigenic peptides useful for hla-a2-positive patients and pharmaceutical comprising the same |
| 09/24/2009 | US20090239805 Human 3 relaxin |
| 09/24/2009 | US20090239801 Modified Fusion Polypeptides |
| 09/24/2009 | US20090239782 High-molecular weight conjugate of resorcinol derivatives |
| 09/24/2009 | US20090239236 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy |
| 09/24/2009 | US20090238896 Compositions and methods for diagnosing and treating melanoma |
| 09/24/2009 | US20090238886 Retro-Inversion Peptides That Target GIT Transport Receptors and Related Methods |
| 09/24/2009 | US20090238878 Solid Nanoparticle Formulation of Water Insoluble Pharmaceutical Substances With Reduced Ostwald Ripening |
| 09/24/2009 | US20090238863 Liposome composition for induction of immunity |
| 09/24/2009 | US20090238843 Recombinant mva capable of expressing structural hcv antigens |